Evaluate the Safety, Tolerability, & Pharmacokinetics of K-285 Compared With Indomethacin Capsule in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 4, 2018

Primary Completion Date

January 6, 2019

Study Completion Date

January 6, 2019

Conditions
Healthy
Interventions
DRUG

K-285

Topical

DRUG

Indomethacin

Capsule

Trial Locations (1)

78744

PPD Development, LP, Austin

Sponsors
All Listed Sponsors
lead

Kowa Research Institute, Inc.

INDUSTRY

NCT03712241 - Evaluate the Safety, Tolerability, & Pharmacokinetics of K-285 Compared With Indomethacin Capsule in Healthy Adults | Biotech Hunter | Biotech Hunter